Purification of human eosinophil-derived neurotoxin - PubMed (original) (raw)
Purification of human eosinophil-derived neurotoxin
D T Durack et al. Proc Natl Acad Sci U S A. 1981 Aug.
Abstract
Human and animal eosinophils contain a powerful neurotoxin that causes selective neuronal and axonal damage to white matter of cerebellum and spinal cord of experimental animals when injected intrathecally. This reaction is termed the "Gordon phenomenon." We purified the eosinophil-derived neurotoxin from eosinophil-rich leukocyte suspensions or eosinophil granules from four patients with various hypereosinophilic syndromes. A single protein with an average molecular weight of 18,400 was isolated by sequential chromatography on Sephadex G-50 columns and analyzed by sodium dodecyl sulfate/polyacrylamide gel electrophoresis of column fractions. The purified eosinophil-derived neurotoxin from the cells of these patients retained the potent neurotoxic activity of the crude eosinophil or eosinophil granule extracts in experimental animals. These animals developed the syndrome of stiffness and ataxia progressing to severe paralysis characteristic of the Gordon phenomenon. Histologic examination of the brains of animals injected with purified eosinophil-derived neurotoxin confirmed the characteristic widespread loss of Purkinje cells and severe spongiform vacuolation in the white matter of cerebellum, brain stem, and spinal cord. We have established the location of eosinophil-derived neurotoxin in the eosinophil granule and have shown that it is distinct from several other eosinophil proteins, the granule major basic protein, and the Charcot-Leyden crystal protein (lysophospholipase).
Similar articles
- Biochemical and functional similarities between human eosinophil-derived neurotoxin and eosinophil cationic protein: homology with ribonuclease.
Gleich GJ, Loegering DA, Bell MP, Checkel JL, Ackerman SJ, McKean DJ. Gleich GJ, et al. Proc Natl Acad Sci U S A. 1986 May;83(10):3146-50. doi: 10.1073/pnas.83.10.3146. Proc Natl Acad Sci U S A. 1986. PMID: 3458170 Free PMC article. - Distinctive cationic proteins of the human eosinophil granule: major basic protein, eosinophil cationic protein, and eosinophil-derived neurotoxin.
Ackerman SJ, Loegering DA, Venge P, Olsson I, Harley JB, Fauci AS, Gleich GJ. Ackerman SJ, et al. J Immunol. 1983 Dec;131(6):2977-82. J Immunol. 1983. PMID: 6644025 - Neurotoxicity of human eosinophils.
Durack DT, Sumi SM, Klebanoff SJ. Durack DT, et al. Proc Natl Acad Sci U S A. 1979 Mar;76(3):1443-7. doi: 10.1073/pnas.76.3.1443. Proc Natl Acad Sci U S A. 1979. PMID: 286329 Free PMC article. - [Biochemistry and biological activities of eosinophil granule proteins].
Enokihara H, Koike T. Enokihara H, et al. Nihon Rinsho. 1993 Mar;51(3):605-12. Nihon Rinsho. 1993. PMID: 7684096 Review. Japanese. - Localization of Charcot-Leyden crystal protein in individual morphological phenotypes of human basophils stimulated by f-Met peptide.
Dvorak AM, MacGlashan DW, Warner JA, Letourneau L, Morgan ES, Lichtenstein LM, Ackerman SJ. Dvorak AM, et al. Clin Exp Allergy. 1997 Apr;27(4):452-74. Clin Exp Allergy. 1997. PMID: 9146940 Review.
Cited by
- Eosinophilic meningoencephalitis successfully treated with glucocorticoids and intravenous immunoglobulin: a case report.
Ahn SH, Ahn SJ, Kim SA, Lee HS, Chu K. Ahn SH, et al. Encephalitis. 2024 Apr;4(2):40-46. doi: 10.47936/encephalitis.2024.00010. Epub 2024 Mar 28. Encephalitis. 2024. PMID: 38545640 Free PMC article. - Non-Invasive and Minimally Invasive Biomarkers for the Management of Eosinophilic Esophagitis beyond Peak Eosinophil Counts: Filling the Gap in Clinical Practice.
Visaggi P, Solinas I, Baiano Svizzero F, Bottari A, Barberio B, Lorenzon G, Ghisa M, Maniero D, Marabotto E, Bellini M, de Bortoli N, Savarino EV. Visaggi P, et al. Diagnostics (Basel). 2023 Aug 30;13(17):2806. doi: 10.3390/diagnostics13172806. Diagnostics (Basel). 2023. PMID: 37685343 Free PMC article. Review. - Monocytic Subsets Impact Cerebral Cortex and Cognition: Differences Between Healthy Subjects and Patients With First-Episode Schizophrenia.
Chen S, Fan F, Xuan FL, Yan L, Xiu M, Fan H, Cui Y, Zhang P, Yu T, Yang F, Tian B, Hong LE, Tan Y, Tian L. Chen S, et al. Front Immunol. 2022 Jul 11;13:900284. doi: 10.3389/fimmu.2022.900284. eCollection 2022. Front Immunol. 2022. PMID: 35898501 Free PMC article. - Could the Epigenetics of Eosinophils in Asthma and Allergy Solve Parts of the Puzzle?
Bélanger É, Laprise C. Bélanger É, et al. Int J Mol Sci. 2021 Aug 19;22(16):8921. doi: 10.3390/ijms22168921. Int J Mol Sci. 2021. PMID: 34445627 Free PMC article. Review. - Strengths and Challenges of Secretory Ribonucleases as AntiTumor Agents.
Castro J, Ribó M, Vilanova M, Benito A. Castro J, et al. Pharmaceutics. 2021 Jan 9;13(1):82. doi: 10.3390/pharmaceutics13010082. Pharmaceutics. 2021. PMID: 33435285 Free PMC article. Review.
References
- J Immunol. 1979 Dec;123(6):2925-7 - PubMed
- Biochemistry. 1971 Jun 22;10(13):2606-17 - PubMed
- Blood. 1978 Mar;51(3):457-73 - PubMed
- J Exp Med. 1974 Aug 1;140(2):313-32 - PubMed
- Neurology. 1966 Nov;16(11):1118-26 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources